Picture of Initiator Pharma A/S logo

INIT Initiator Pharma A/S News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Initiator Pharma Reports Positive Results From Toxicology Study

Dec 15 (Reuters) - Initiator Pharma A/S  INIT.TE : 
    * INITIATOR PHARMA REPORTS POSITIVE RESULTS FROM THE 28 DAYS 
TOXICOLOGY STUDY IN MINI-PIGS FOR ITS LEAD DRUG CANDIDATE 
IPED2015 
    * AIM OF INITIATING A PHASE 1 CLINICAL TRIAL NEXT YEAR. 
 
Source text for Eikon:  ID:nWkr7FGdqZ  
Further company coverage:  INIT.TE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Initiator Pharma A/S

See all news